Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

PLD is an effective and safer alternative for treating breast cancer.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Some breast cancer chemotherapy can cause permanent hair loss.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Tamoxifen caused hair loss in a 52-year-old woman.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Breast cancer patients need strong psychological support to improve their quality of life.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Gene variation affects prostate issues and hair loss.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.